Oxidative Stress and Advanced Glycation End Products in Hashimoto's Thyroiditis

Thyroid

Volumn 26, Issue 4, 2016, Pages 504-511

  Ruggeri, Rosaria M ^a   Vicchio, Teresa M ^a   Cristani, Mariateresa ^b   Certo, Rosaria ^a   Caccamo, Daniela ^b   Alibrandi, Angela ^b   Giovinazzo, Salvatore ^a   Saija, Antonina ^b   Campennì, Alfredo ^b   Trimarchi, Francesco ^a,b   Gangemi, Sebastiano ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; LIOTHYRONINE; REACTIVE OXYGEN METABOLITE; THYROID ANTIBODY; THYROTROPIN; THYROXINE; ANTIOXIDANT; BIOLOGICAL MARKER; FREE RADICAL; OXIDIZING AGENT; OXYGEN;

ADOLESCENT; ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HASHIMOTO DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; POWER ANALYSIS; PRIORITY JOURNAL; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; CHEMISTRY; ECHOGRAPHY; HOMEOSTASIS; MIDDLE AGED; OXIDATION REDUCTION REACTION; PATHOLOGY; THYROID GLAND;

ADULT; ANTIOXIDANTS; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; FREE RADICALS; GLYCOSYLATION END PRODUCTS, ADVANCED; HASHIMOTO DISEASE; HOMEOSTASIS; HUMANS; MALE; MIDDLE AGED; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXYGEN; THYROID GLAND; THYROTROPIN; THYROXINE; ULTRASONOGRAPHY;

EID: 84963930549     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2015.0592     Document Type: Article

References (47)

1. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J 2007 Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44-84.
2. McCord JM 1993 Human disease, free radicals, and the oxidant/antioxidant balance. Clin Biochem 26:351-357.
3. Uttara B, Singh AV, Zamboni P, Mahajan RT 2009 Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 7:65-74.
4. PerlA2013Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nat Rev Rheumatol 9:674-686.
5. Grygiel-Gorniak B, Puszczewicz M 2014 Oxidative damage and antioxidative therapy in systemic sclerosis. Mediators Inflamm 2014:389582.
6. Abalovich M, Llesuy S, Gutierrez S, Repetto M 2003 Peripheral parameters of oxidative stress in Graves' disease: The effects of methimazole and 131 iodine treatments. Clin Endocrinol (Oxf) 59:321-327.
7. Bednarek J, Wysocki H, Sowiński J 2005 Oxidative stress peripheral parameters in Graves' disease: The effect of methimazole treatment in patients with and without infiltrative ophthalmopathy. Clin Biochem 38:13-18.
8. Rostami R, Aghasi MR, Mohammadi A, Nourooz-Zadeh J 2013 Enhanced oxidative stress in Hashimoto's thyroiditis: inter-relationships to biomarkers of thyroid function. Clin Biochem 46:308-312.
9. Resch U, Helsel G, Tatzber F, Sinzinger H 2002 Antioxidant status in thyroid dysfunction. Clin Chem Lab Med 40:1132-1134.
10. Erdamar H, Demirici H, Yaman H, Erbil MK, Yakar T, Sancak B, Elbeg S, Biberoglu G, Yetkin I 2008 The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status. Clin Chem Lab Med 46:1004-1010.
11. Mancini A, Raimondo S, Di Segni C, Persano M, Gadotti G, Silvestrini A, Festa R, Tiano L, Pontecorvi A, Meucci E 2013 Thyroid hormones and antioxidant systems: focus on oxidative stress in cardiovascular and pulmonary diseases. Int J Mol Sci 14:23893-23909.
12. Song Y, Driessens N, Costa M, De Deken X, Detours V, Corvilain B, Maenhaut C, Miot F, Van Sande J, Many MC,Dumont JE 2007 Roles of hydrogen peroxide in thyroid physiology and disease. J Clin Endocrinol Metab 92:3764-3773.
13. Baskol G, Atmaca H, Tanriverdi F, Baskol M, Kocer D, Bayram F 2007 Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment. Exp Clin Endocrinol Diabetes 115:522-526.
14. Torun AN, Kulaksizoglu S, Kulaksizoglu M, Pamuk BO, Isbilen E, Tutuncu NB 2009 Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clin Endocrinol (Oxf) 70:469-474.
15. Aslan M, Cosar N, Celik H, Aksoy N, Dulger AC, Begenik H, Soyoral YU, Kucukoglu ME, Selek S 2011 Evaluation of oxidative status in patients with hyperthyroidism. Endocrine 40:285-289.
16. Reddy VS, Gouroju S, Suchitra MM, Suresh V, Sachan A, Srinivasa Rao PV, Bitla AR 2013 Antioxidant defense in overt and subclinical hypothyroidism. Horm Metab Res 45:754-758.
17. Marcocci C, Bartalena L 2013 Role of oxidative stress and selenium in Graves' hyperthyroidism and orbitopathy. J Endocrinol Invest 36:15-20.
18. Ates I, Yilmaz FM, Altay M, Yilmaz N, Berker D, Güler S 2015 The relationship between oxidative stress and autoimmunity in Hashimoto's thyroiditis. Eur J Endocrinol 173:791-799.
19. Baser H, Can U, Baser S, Yerlikaya FH, Aslan U, Hidayetoglu BT 2014 Assessment of oxidative status and its association with thyroid autoantibodies in patients with euthyroid autoimmune thyroiditis. Endocrine 48:916-923.
20. Kalousová M, Zima T, Tesar V, Dusilová-Sulková S, Skrha J 2005 Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutat Res 579:37-46.
21. Piwowar A 2010 Advanced oxidation protein products. Part I. Mechanism of the formation, characteristics and property. Pol Merkuriusz Lek 28:166-169.
22. Brent GA, Davies TF 2012 Hypothyroidism and thyroiditis. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds) Williams Textbook of Endocrinology. Twelfth edition. Saunders, Philadelphia, PA, pp 423-456.
23. Vejbjerg P, Knudsen N, Perrild H, Laurberg P, Pedersen IB, Rasmussen LB, Ovesen L, Jørgensen T 2006 The association between hypoechogenicity or irregular echo pattern at thyroid ultrasonography and thyroid function in the general population. Eur J Endocrinol 155:547-552.
24. Gangemi S, Minciullo PL, Magliacane D, Saitta S, Loffredo S, Saija A, Cristani M, Marone G, Triggiani M 2015 Oxidative stress markers are increased in patients with mastocytosis. Allergy 70:436-442.
25. de Groot E, van Leuven SI, Duivenvoorden R, Meuwese MC, Akdim F, Bots ML, Kastelein JJ 2008 Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis. Nat Clin Pract Cardiovasc Med 5:280-288.
26. Guerra LN, Moiguer S, Karner M, de Molina MC, Sreider CM, Burdman JA 2001 Antioxidants in the treatment of Grave's disease. IUBMB Life 51:105-109.
27. Vrca VB, Skreb F, Cepelak I, Romic Z, Mayer L 2004 Supplementation with antioxidants in the treatment of Graves' disease; the effect on glutathione peroxidase activity and concentration of selenium. Clin Chim Acta 341:55-63.
28. Marcocci C, Kahaly GJ, Krassas GE, Bartalena L, Prummel M, Stahl M, Altea MA, Nardi M, Pitz S, Boboridis K, Sivelli P, von Arx G, Mourits MP, Baldeschi L, Bencivelli W, Wiersinga W, The European Group on Graves' Orbitopathy 2011 Selenium and the course of mild Graves' orbitopathy. N Engl J Med 364:1920-1931.
29. Duntas LH 2015 The role of iodine and selenium in autoimmune thyroiditis. Horm Metab Res 47:721-726.
30. Wang W, Xue H, Li Y, Hou X, Fan C, Zhang H, Wang H, Shan Z, Teng W 2015 Effects of selenium supplementation on spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. Thyroid 25:1137-1144.
31. Colin IM, Poncin S, Levêque P, Gallez B, Gérard AC 2014 Differential regulation of the production of reactive oxygen species in Th1 cytokine-treated thyroid cells. Thyroid 24:441-452.
32. Marique L, Van Regemorter V, Gérard AC, Craps J, Senou M, Marbaix E, Rahier J, Daumerie C, Mourad M, Lengelé B, Colin IM, Many MC 2014 The expression of dual oxidase, thyroid peroxidase, and caveolin-1 differs according to the type of immune response (TH1/TH2) involved in thyroid autoimmune disorders. J Clin Endocrinol Metab 99:1722-1732.
33. Jackson SH, Devadas S, Kwon J, Pinto LA, Williams MS 2004 T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol 5:818-827.
34. Williams MS, Kwon J 2004 T cell receptor stimulation, reactive oxygen species, and cell signaling. Free Radic Biol Med 37:1144-1151.
35. Davies CM, Guilak F, Weinberg JB, Fermor B 2008 Reactive nitrogen and oxygen species in interleukin-1-mediated DNA damage associated with osteoarthritis. Osteoarthr Cartilage 16:624-630.
36. Rabinovitch A, Suarez-Pinzon WL, Strynadka K, Lakey JR, Rajotte RV 1996 Human pancreatic islet b-cell destruction by cytokines involves oxygen free radicals and aldehyde production. J Clin Endocrinol Metab 81:3197-3202.
37. Ahsan H, Ali A, Ali R 2003 Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol 131:398-404.
38. Kurien BT, Scofield RH 2008 Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 7:567-573.
39. Laddha NC, Dwivedi M, Mansuri MS, Gani AR, Ansarullah M, Ramachandran AV, Dalai S, Begum R 2013 Vitiligo: interplay between oxidative stress and immune system. Exp Dermatol 22:245-250.
40. Reddy SV, Suchitra MM, Pradeep V, Alok S, Suresh V, Bitla AR, Srinivasa Rao PV 2015 Ischemia-modified albumin levels in overt and subclinical hypothyroidism. J Endocrinol Invest 38:885-890.
41. Korkmaz H, Tabur S, Ozkaya M, Oguz E, Aksoy N, Akarsu E 2015 Serum prolidase levels in Graves' disease without ophthalmopathy and its association with oxidative status. J Endocrinol Invest 38:1167-1173.
42. Zurawska-Paksej E, Grzebyk E, Marciniak D, Szymańska-Chabowska A, Piwowar A 2014 Oxidatively modified forms of albumin in patients with risk factors of metabolic syndrome. J Endocrinol Invest 37:819-827.
43. Nenna A, Spadaccio C, Lusini M, Ulianich L, Chello M, Nappi F 2015 Basic and clinical research against Advanced Glycation End Products (AGEs): new compounds to tackle cardiovascular disease and diabetic complications. Recent Pat Cardiovasc Drug Discov 10:10-33.
44. de Groot L, Hinkema H, Westra J, Smit AJ, Kallenberg CG, Bijl M, Posthumus MD 2011 Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease. Arthritis Res Ther 13:R205.
45. Sternberg Z, Ostrow P, VaughanM, Chichelli T, Munschauer F 2011 AGE-RAGE in multiple sclerosis brain. Immunol Invest 40:197-205.
46. Musolino C, Allegra A, Saija A, Alonci A, Russo S, Spatari G, Penna G, Gerace D, CristaniM, David A, Saitta S, Gangemi S 2012 Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia. Clin Biochem 45:1439-1443.
47. D'Adamo E, De Leonibus C, Giannini C, Corazzini V, De Remigis A, Chiarelli F, Mohn A 2012 Thyroid dysfunction in obese pre-pubertal children: oxidative stress as a potential pathogenetic mechanism. Free Radic Res 46: 303-309.